Contact
searchSearch
HMP Global
Login

Schizophrenia Excellence Forum

Schizophrenia
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Podcasts
New Mechanisms of Action in Psychiatry With Dr Craig Chepke
09/14/2022
In this podcast excerpt, Craig Chepke, MD, FAPA, psychiatrist and medical director at Excel Psychiatric Associates in Huntersville, North Carolina, discusses the new mechanisms of action (MOAs) that could help to improve patient care in the...
In this podcast excerpt, Craig Chepke, MD, FAPA, psychiatrist and medical director at Excel Psychiatric Associates in Huntersville, North Carolina, discusses the new mechanisms of action (MOAs) that could help to improve patient care in the...
In this podcast excerpt, Craig...
09/14/2022
Psych Congress Network
Leslie Citrome and Saundra Jain.
Podcasts
Optimizing Schizophrenia Treatment Through LAIs
09/07/2022
In this podcast, Schizophrenia Section Editor, Leslie Citrome, MD, MPH, explains why LAIs are never a last resort, how to choose the specific formulation to use, overcoming a patient's aversion to needles, and more.
In this podcast, Schizophrenia Section Editor, Leslie Citrome, MD, MPH, explains why LAIs are never a last resort, how to choose the specific formulation to use, overcoming a patient's aversion to needles, and more.
In this podcast, Schizophrenia...
09/07/2022
Psych Congress Network
Podcasts
Case Managers, Telepsychiatry Offer Consistency in Schizophrenia Treatment
08/24/2022
Amber Hoberg, NP, discusses meeting her patients with schizophrenia "where they are" to provide treatment.
Amber Hoberg, NP, discusses meeting her patients with schizophrenia "where they are" to provide treatment.
Amber Hoberg, NP, discusses...
08/24/2022
Psych Congress Network
Quiz
When should clozapine be offered as a treatment option?
08/19/2022
Take the quiz to test your clinical knowledge!
Take the quiz to test your clinical knowledge!
Take the quiz to test your...
08/19/2022
Psych Congress Network
Kraus, Citrome, and Yeiser.
Podcasts
Treatment Options and Managing Side Effects in Schizophrenia
08/10/2022
In this podcast, Leslie L. Citrome, MD, MPH, Clinical Professor of Psychiatry and Behavioral Sciences, New York Medical College; Rebecca Kraus, MSPAS, PA-C; and Bethany Yeiser, BS, President, CURESZ Foundation, answer questions about treating...
In this podcast, Leslie L. Citrome, MD, MPH, Clinical Professor of Psychiatry and Behavioral Sciences, New York Medical College; Rebecca Kraus, MSPAS, PA-C; and Bethany Yeiser, BS, President, CURESZ Foundation, answer questions about treating...
In this podcast, Leslie L....
08/10/2022
Psych Congress Network
Podcasts
How TAAR1 Agonists Might Be Used in Schizophrenia Treatment, With Dr Leslie Citrome
08/02/2022
In this podcast, Psych Congress Network's Schizophrenia Section Editor Leslie L. Citrome, MD, MPH, answers questions about the potential uses of TAAR1 agonists in the treatment of schizophrenia. Andrew Penn, MS, PMHNP, moderates.
In this podcast, Psych Congress Network's Schizophrenia Section Editor Leslie L. Citrome, MD, MPH, answers questions about the potential uses of TAAR1 agonists in the treatment of schizophrenia. Andrew Penn, MS, PMHNP, moderates.
In this podcast, Psych Congress...
08/02/2022
Psych Congress Network
Dr Jonathan M. Meyer.
Videos
Tailoring Treatment to Patient Goals and Providing the Clozapine Option as Standard of Care With Dr Jonathan M. Meyer
07/18/2022
Jonathan M. Meyer, MD, provides insights on how to prioritize patients' goals for treatment and the importance of offering clozapine as an option to treatment resistant patients.
Jonathan M. Meyer, MD, provides insights on how to prioritize patients' goals for treatment and the importance of offering clozapine as an option to treatment resistant patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Dr Jonathan M Meyer
Videos
Making Space for Patient Needs When Treating First-Episode Schizophrenia With Dr Jonathan M. Meyer
07/14/2022
Jonathan Meyer, MD, explains how to account for each patient's unique needs and concerns, frame the benefit of medications around patient goals, and bring up long-acting injectables (LAIs).
Jonathan Meyer, MD, explains how to account for each patient's unique needs and concerns, frame the benefit of medications around patient goals, and bring up long-acting injectables (LAIs).
Jonathan Meyer, MD, explains...
07/14/2022
Psych Congress Network
Ilan Melnick, MD.
Videos
Intervening Early With Long-Acting Injectables
07/05/2022
In this video, Psych Congress Steering Committee member Ilan Melnick, MD, explains the benefits of early patient intervention using long-acting injectables (LAIs) to achieve stability and treatment adherence.
In this video, Psych Congress Steering Committee member Ilan Melnick, MD, explains the benefits of early patient intervention using long-acting injectables (LAIs) to achieve stability and treatment adherence.
In this video, Psych Congress...
07/05/2022
Psych Congress Network
Rebecca Kraus.
Videos
Overcoming Schizophrenia Treatment Challenges and the Potential of TAAR1
06/22/2022
Rebecca Kraus, MSPS, PA-C, explains common treatment challenges that clinicians encounter when treating patients with schizophrenia, barriers to accessing treatment, and the exciting potential of trace amine-associated receptor (TAAR1)...
Rebecca Kraus, MSPS, PA-C, explains common treatment challenges that clinicians encounter when treating patients with schizophrenia, barriers to accessing treatment, and the exciting potential of trace amine-associated receptor (TAAR1)...
Rebecca Kraus, MSPS, PA-C,...
06/22/2022
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use